Literature DB >> 29700094

Genetics of alcoholic liver disease and non-alcoholic steatohepatitis.

Emma Scott1, Quentin M Anstee2.   

Abstract

Alcohol-related liver disease (ARLD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver disease globally. Both ARLD and NAFLD are multifactorial and refer to a spectrum of disease severity, ranging from steatosis through steatohepatitis to fibrosis and cirrhosis. Both diseases exhibit substantial inter-patient variation in long-term outcomes and are best considered complex disease traits where genetic and environmental factors interact to mediate disease severity and progression. Here, we briefly review the current literature describing the best validated genetic modifiers that influence severity of these liver conditions, including variants of the genes PNPLA3, TM6SF2 and MBOAT7, which have also been implicated in lipid dysregulation. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  ARLD; NAFLD; PNPLA3; TM6SF2; cirrhosis; gene

Mesh:

Substances:

Year:  2018        PMID: 29700094      PMCID: PMC6334028          DOI: 10.7861/clinmedicine.18-2-s54

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  32 in total

1.  A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.

Authors:  Stephan Buch; Felix Stickel; Eric Trépo; Michael Way; Alexander Herrmann; Hans Dieter Nischalke; Mario Brosch; Jonas Rosendahl; Thomas Berg; Monika Ridinger; Marcella Rietschel; Andrew McQuillin; Josef Frank; Falk Kiefer; Stefan Schreiber; Wolfgang Lieb; Michael Soyka; Nasser Semmo; Elmar Aigner; Christian Datz; Renate Schmelz; Stefan Brückner; Sebastian Zeissig; Anna-Magdalena Stephan; Norbert Wodarz; Jacques Devière; Nicolas Clumeck; Christoph Sarrazin; Frank Lammert; Thierry Gustot; Pierre Deltenre; Henry Völzke; Markus M Lerch; Julia Mayerle; Florian Eyer; Clemens Schafmayer; Sven Cichon; Markus M Nöthen; Michael Nothnagel; David Ellinghaus; Klaus Huse; Andre Franke; Steffen Zopf; Claus Hellerbrand; Christophe Moreno; Denis Franchimont; Marsha Y Morgan; Jochen Hampe
Journal:  Nat Genet       Date:  2015-10-19       Impact factor: 38.330

2.  Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

Authors:  Y-L Liu; G L Patman; J B S Leathart; A-C Piguet; A D Burt; J-F Dufour; C P Day; A K Daly; H L Reeves; Q M Anstee
Journal:  J Hepatol       Date:  2014-03-06       Impact factor: 25.083

3.  TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.

Authors:  A Grandone; D Cozzolino; P Marzuillo; G Cirillo; A Di Sessa; L Ruggiero; M R Di Palma; L Perrone; E Miraglia Del Giudice
Journal:  Pediatr Obes       Date:  2015-04-20       Impact factor: 4.000

4.  Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans.

Authors:  Z Hrubec; G S Omenn
Journal:  Alcohol Clin Exp Res       Date:  1981       Impact factor: 3.455

5.  TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.

Authors:  Hovsep Mahdessian; Apostolos Taxiarchis; Sergej Popov; Angela Silveira; Anders Franco-Cereceda; Anders Hamsten; Per Eriksson; Ferdinand van't Hooft
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-04       Impact factor: 11.205

6.  Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.

Authors:  Yanbo Fan; Haocheng Lu; Yanhong Guo; Tianqing Zhu; Minerva T Garcia-Barrio; Zhisheng Jiang; Cristen J Willer; Jifeng Zhang; Y Eugene Chen
Journal:  Gastroenterology       Date:  2016-01-13       Impact factor: 22.682

7.  Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity.

Authors:  Silvia Sookoian; Gustavo O Castaño; Romina Scian; Pablo Mallardi; Tomas Fernández Gianotti; Adriana L Burgueño; Julio San Martino; Carlos J Pirola
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

8.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.

Authors:  Xin Yuan; Dawn Waterworth; John R B Perry; Noha Lim; Kijoung Song; John C Chambers; Weihua Zhang; Peter Vollenweider; Heide Stirnadel; Toby Johnson; Sven Bergmann; Noam D Beckmann; Yun Li; Luigi Ferrucci; David Melzer; Dena Hernandez; Andrew Singleton; James Scott; Paul Elliott; Gerard Waeber; Lon Cardon; Timothy M Frayling; Jaspal S Kooner; Vincent Mooser
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

9.  Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.

Authors:  Salvatore Petta; Luca Miele; Elisabetta Bugianesi; Calogero Cammà; Chiara Rosso; Stefania Boccia; Daniela Cabibi; Vito Di Marco; Stefania Grimaudo; Antonio Grieco; Rosaria Maria Pipitone; Giulio Marchesini; Antonio Craxì
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Authors:  Yang-Lin Liu; Helen L Reeves; Alastair D Burt; Dina Tiniakos; Stuart McPherson; Julian B S Leathart; Michael E D Allison; Graeme J Alexander; Anne-Christine Piguet; Rodolphe Anty; Peter Donaldson; Guruprasad P Aithal; Sven Francque; Luc Van Gaal; Karine Clement; Vlad Ratziu; Jean-Francois Dufour; Christopher P Day; Ann K Daly; Quentin M Anstee
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919

View more
  7 in total

1.  Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.

Authors:  Michelle T Long; Ellen B Gurary; Joseph M Massaro; Jiantao Ma; Udo Hoffmann; Raymond T Chung; Emelia J Benjamin; Rohit Loomba
Journal:  Liver Int       Date:  2018-09-25       Impact factor: 5.828

2.  Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Arun J Sanyal; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2019-03-07       Impact factor: 17.425

3.  Loss of hepatic Mboat7 leads to liver fibrosis.

Authors:  Veera Raghavan Thangapandi; Oskar Knittelfelder; Mario Brosch; Eleonora Patsenker; Olga Vvedenskaya; Stephan Buch; Sebastian Hinz; Alexander Hendricks; Marina Nati; Alexander Herrmann; Devavrat Ravindra Rekhade; Thomas Berg; Madlen Matz-Soja; Klaus Huse; Edda Klipp; Josch K Pauling; Judith Ah Wodke; Jacobo Miranda Ackerman; Malte von Bonin; Elmar Aigner; Christian Datz; Witigo von Schönfels; Sophie Nehring; Sebastian Zeissig; Christoph Röcken; Andreas Dahl; Triantafyllos Chavakis; Felix Stickel; Andrej Shevchenko; Clemens Schafmayer; Jochen Hampe; Pallavi Subramanian
Journal:  Gut       Date:  2020-06-26       Impact factor: 23.059

Review 4.  The Translational Bridge between Inflammation and Hepatocarcinogenesis.

Authors:  Sabine Gufler; Rita Seeboeck; Christoph Schatz; Johannes Haybaeck
Journal:  Cells       Date:  2022-02-03       Impact factor: 6.600

Review 5.  Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis.

Authors:  Claudia Bocca; Francesca Protopapa; Beatrice Foglia; Marina Maggiora; Stefania Cannito; Maurizio Parola; Erica Novo
Journal:  Antioxidants (Basel)       Date:  2022-06-28

Review 6.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

7.  First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involved.

Authors:  Shuang Zhao; Shuman Zhang; Weiwei Zhang; Yi Gao; Chengbo Rong; Hexiang Wang; Yu Liu; Jack Ho Wong; Tzibun Ng
Journal:  Sci Rep       Date:  2019-09-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.